Efficacy of Multi-Gyn ActiGel for treatment of vaginal infections

Many women suffer from vaginal infections (mostly candidiasis or bacterial vaginosis) and associated complaints such as itch, malodor and abnormal discharge. Although these conditions hardly ever have serious medical consequences, they can severele affect the quality of life of women that suffer from these conditions. Standard treatment of vaginal infections consists of antibiotic or antimycotic therapy, but these drugs have several side-effects and also recurrence rates are very high. Multi-Gyn ActiGel is a natural alternative to antimicrobial agents that contains patented anti-adhesive polysaccharides (called 2QR-complex) to correct the healthy vaginal microflora. In this study we aim to assess the efficacy of ActiGel over a placebo gel to treat vaginal infections and the associated complaints. Multi-Gyn ActiGel is a substance-based medical device class IIa.

Multi-Gyn ActiGel is effective to treat vaginal infections and relief symptoms related to this condition.

Women will be treated for 5 days, and will return to the gynaecologist between day 5-8 from the start of treatment

Women that present themselves with a vaginal infection at the gyneacologist will use Multi-Gyn ActiGel or placebo for 5 days, twice per day. At study entry and at follow up women will be physically examined, and a vaginal swab will be obtained for microscopy, cytology and pH measurement.